drugset / Trial / NCT00221429

Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder

NCT00221429

RandomizedParallel-groupTriple-blindTreatment

Summary

This study compared the efficacy of lithium, divalproex, and placebo in treating the acute phase of symptomatic bipolar I disorder, mixed or manic episode, in children and adolescents.

Timeline

Start
2001-03
Primary completion
2006-08
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Divalproex Sodium Small molecule
Subject Lithium Unknown

Indications